Intravenously injected clusterin binds to brain endothelial cells and can reduce neuroinflammatory gene expression in a mouse model of acute brain inflammation and Alzheimer’s disease (De Miguel et al., 2021). The gene discussed is CLU; the disease is early-onset autosomal dominant Alzheimer disease.